A Study of INCB050465 in Primary Sjögren's Syndrome

Status:
Completed

Trial end date:
2020-01-02

Target enrollment:

Participant gender:

The purpose of this study is to assess the impact of parsaclisib on the signs and symptoms of Sjögren's syndrome (SS).

Phase 2

Incyte Corporation